Syndax Pharmaceuticals Inc
Ticker: 1395937
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2026 | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q3 FY2021 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 72.79+12.2% | 64.86+41.4% | 45.87+20.8% | 37.96+89.4% | 20.04+60.3% | 12.50+257.1% | 3.50-71.7% | 12.38 |
| Total Income | 72.79+12.2% | 64.86+41.4% | 45.87+20.8% | 37.96+89.4% | 20.04+60.3% | 12.50+257.1% | 3.50-71.7% | 12.38 |
| EXPENSES | ||||||||
| Expenditure | 112.78+13.8% | 99.07-4.1% | 103.30-3.7% | 107.31+3.4% | 103.80+1.7% | 102.08+31.3% | 77.72+139.8% | 32.41 |
| Tax | — | 0.00 | — | — | 0.00 | — | — | — |
| PROFIT | ||||||||
| Net Profit | -49.36-15.7% | -42.67+29.7% | -60.72+15.5% | -71.85+15.3% | -84.85-0.9% | -84.13-23.6% | -68.06-229.7% | -20.64 |
| KEY METRICS | ||||||||
| OPM % | -54.95%-2.22pp | -52.73%+47.27pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -67.82%-2.03pp | -65.79%+34.21pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.55-14.6% | -0.48+31.4% | -0.70+15.7% | -0.83+15.3% | -0.98+0.0% | -0.98-22.5% | -0.80 | — |
Corporate Events
Board MeetingSNDX
202610Jun
Board Meeting
Annual Meeting of Stockholders held on June 10, 2026, where …
SEC Filing ↗